Latest Respiratory diseases Stories

BRISBANE, Calif., July 17, 2012 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that it will release its second quarter and first six months 2012 financial results prior to the open of the U.S. markets on Monday, July 23, 2012. A live conference call and webcast will be hosted by InterMune at 8:30 a.m. Eastern time that same day. Interested investors and others may participate in the conference call by dialing 800-891-8257 (U.S.) or +1 212-271-4651 (international),...

RESEARCH TRIANGLE PARK, N.C., July 17, 2012 /PRNewswire/ -- Grifols, a global healthcare company based in Barcelona, Spain, today announced plans to initiate a safety trial of a novel, inhaled formulation of alpha1-proteinase inhibitor [Human] later this year. In April, the U.S. Food and Drug Administration (FDA) granted orphan drug designation for Grifols' inhaled alpha1 formulation as a treatment for cystic fibrosis, an inherited disease that can cause life-threatening lung...

The Mesothelioma Victims Center says, "We want nothing but the best for a family dealing with a loss of a family member to a rare form of cancer called mesothelioma. Provided it's been less than a few years after the loss, we would still like to give the family the names of the best mesothelioma law firms in the nation, along with their specific contacts, with the hope one of these very capable law firms can try to get some significant compensation for the family. In some...

Landmark Decision Upholding ACA Should Mean Lifesaving Medical Coverage for Mesothelioma, Other Cancer Victims, Gary Cohn Reports on Behalf of the Mesothelioma Cancer Alliance (PRWEB) July 11, 2012 Pulitzer Prize-winning investigative journalist Gary Cohn takes an unwavering look at the impact the Supreme Court of the United States' (SCOTUS) decision to uphold the Affordable Care Act (ACA) has on cancer victims and their on-going battle against the disease in “The Dignity of Medical...

OXFORD, England, July 5, 2012 /PRNewswire/ -- Prosonix (Oxford, UK) announced that it has signed a Collaborative Research Agreement with Imperial College London to accelerate the development of engineered Multi-component Particles (MCPs(TM)) as respiratory medicines. The collaboration will see Prosonix working closely with Dr Omar Usmani, an internationally recognised expert in respiratory diseases and inhaled drug delivery at the College's National Heart and Lung...

Foundation Gives Its Condolences and Heartfelt Gratitude to the Family of Dr. I.M. Rosenzweig and Will Name Research Award in His Honor CHICAGO, June 29, 2012 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation is deeply saddened to announce the recent death of one of its co-founders, I.M. Rosenzweig, PhD. Mike, as he was known to all, lost his courageous battle with idiopathic pulmonary fibrosis (IPF) on June 23, 2012. Mike, who was a clinical psychologist,...

STOCKHOLM, June 28, 2012 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today reported that the Swedish Dental and Pharmaceutical Benefits Agency (TLV) has included Esbriet® (pirfenidone) on Sweden's list of reimbursed drugs, making Esbriet the first medicine for the treatment of idiopathic pulmonary fibrosis (IPF) to be reimbursed in Sweden. Magnus Skold, Professor and Consultant at the Lung and Allergy Clinic at Karolinska University Hospital, said, "Esbriet is a clear step...

Only 5 percent worried about lung disease, despite it being a leading cause of death New data released by the Forum of International Respiratory Societies (FIRS) to coincide with World Spirometry Day today has revealed a worrying lack of understanding and concern among the public about the world's biggest killer - lung disease, which now claims the lives of almost 4 million people a year. Despite the high incidence of lung disease, research conducted by YouGov across four continents...

CHICAGO, June 27, 2012 /PRNewswire/ -- The American College of Chest Physicians (ACCP), OneBreath®, the COPD Alliance, and thousands of organizations worldwide will unite on World Spirometry Day, June 27, to promote lung health and elevate the status of often overlooked lung conditions, reinforcing the value of spirometry in the diagnosis of these conditions. Spirometry, which translated means "measuring of breath," is one of the few examinations in medicine that is extremely...

LONDON, June 27, 2012 /PRNewswire/ -- New data released by the Forum of International Respiratory Societies (FIRS) to coincide with World Spirometry Day today has revealed a lack of understanding and concern among the public about the world's biggest killer[1] - lung disease, which now claims the lives of almost 4 million people a year[2]. Despite the high incidence of lung disease, research conducted by YouGov across four continents revealed that people are more...